Literature DB >> 8773598

Mitochondrial DNA and RNA processing in MELAS.

P Kaufmann1, Y Koga, S Shanske, M Hirano, S DiMauro, M P King, E A Schon.   

Abstract

Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), a maternally inherited disorder, is usually associated with a point mutation in mitochondrial DNA (mtDNA) at position 3,243 in the tRNA Leu(UUR) gene. To further study the pathogenesis of MELAS, we analyzed tissues from 8 MELAS-3,243 patients. Southern blot analysis showed an increase in the ratio of mtDNA to nuclear DNA in almost all tissues examined, implying that mitochondrial proliferation is ubiquitous and is not confined to ragged-red fibers in muscle. By northern blot analysis, we demonstrated increased steady-state levels of RNA 19, a polycistronic transcript corresponding to the 16S rRNA + tRNA Leu(UUR) + ND1 genes (which are contiguous in the mtDNA) in heart, kidney, and muscle. These results provide further evidence that altered mitochondrial nucleic acid metabolism may have pathogenic significance in MELAS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8773598     DOI: 10.1002/ana.410400208

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

1.  Large functional range of steady-state levels of nuclear and mitochondrial transcripts coding for the subunits of the human mitochondrial OXPHOS system.

Authors:  Hervé Duborjal; Réjane Beugnot; Bénédicte Mousson de Camaret; Jean-Paul Issartel
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

2.  Comparative analysis of the pathogenic mechanisms associated with the G8363A and A8296G mutations in the mitochondrial tRNA(Lys) gene.

Authors:  Belén Bornstein; José Antonio Mas; Clarice Patrono; Miguel Angel Fernández-Moreno; Emiliano González-Vioque; Yolanda Campos; Rosalba Carrozzo; Miguel Angel Martín; Pilar del Hoyo; Filippo M Santorelli; Joaquín Arenas; Rafael Garesse
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

3.  Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation.

Authors:  Angela Pyle; Robert W Taylor; Steve E Durham; Marcus Deschauer; Andrew M Schaefer; David C Samuels; Patrick F Chinnery
Journal:  J Med Genet       Date:  2006-09-01       Impact factor: 6.318

Review 4.  Mitochondrial genotype and clinical phenotype.

Authors:  P F Chinnery; D M Turnbull
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 5.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 6.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes.

Authors:  Ronghua Li; Min-Xin Guan
Journal:  Mol Cell Biol       Date:  2010-03-01       Impact factor: 4.272

8.  MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity.

Authors:  M G Hanna; I P Nelson; J A Morgan-Hughes; N W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

9.  Overexpressed mitochondrial leucyl-tRNA synthetase suppresses the A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene.

Authors:  Hyejeong Park; Edgar Davidson; Michael P King
Journal:  RNA       Date:  2008-09-16       Impact factor: 4.942

10.  Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers.

Authors:  Nora Weiduschat; Petra Kaufmann; Xiangling Mao; Kristin Marie Engelstad; Veronica Hinton; Salvatore DiMauro; Darryl De Vivo; Dikoma Shungu
Journal:  Neurology       Date:  2014-01-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.